tucmas.fi BBS

Different therapeutic choices (eculizimab, plasma exchange) are presently being explored. Patients with a private historical past of breast cancer, identified excessive-danger lesions (atypical ductal/lobular hyperplasias and lobular carcinoma in situ), or genetic mutations were excluded from this a...